{"transactions":[{"id":4129,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2026-09-04T10:30:09.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":970,"price":234.73,"value":227688.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":51803,"source":{"system":"sec-edgar","filing":"0000943819-26-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000094381926000050/form4.xml","form_type":"4"}},{"id":694684,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2026-08-06T18:29:31.000Z","date":"2026-08-05","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":225,"value":1800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":52773,"source":{"system":"sec-edgar","filing":"0000943819-26-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000040/form4.xml","form_type":"4"}},{"id":737601,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:01:54.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000828","document":"e665583_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380526000828/e665583_4-farrell.xml","form_type":"4"}},{"id":821306,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2026-04-02T17:52:28.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":225,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":60773,"source":{"system":"sec-edgar","filing":"0000943819-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000019/form4.xml","form_type":"4"}},{"id":859609,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2026-03-05T19:51:36.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":260.22,"value":520440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":62773,"source":{"system":"sec-edgar","filing":"0000943819-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000014/form4.xml","form_type":"4"}},{"id":916606,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2026-02-06T16:07:47.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":251.31,"value":502620.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":64773,"source":{"system":"sec-edgar","filing":"0000943819-26-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000010/form4.xml","form_type":"4"}},{"id":942656,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2026-01-09T12:33:05.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":248.83,"value":497660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":66773,"source":{"system":"sec-edgar","filing":"0000943819-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000004/form4.xml","form_type":"4"}},{"id":980687,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-12-04T18:46:37.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":251.47,"value":502940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":68773,"source":{"system":"sec-edgar","filing":"0000943819-25-000186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000186/form4.xml","form_type":"4"}},{"id":987901,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock Options","published_at":"2025-11-26T20:26:53.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":1331,"price":250.52,"value":333442.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the date on which options first become exercisable. The options vest on the earlier of (i)  November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date."}],"balance_after":1331,"derivative":{"exercise_price":250.52,"exercise_date":"2026-11-11","expiration_date":"2032-11-11","underlying":"ResMed Common Stock","underlying_shares":1331},"source":{"system":"sec-edgar","filing":"0000943819-25-000182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000182/form4.xml","form_type":"4"}},{"id":990599,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-11-24T14:39:33.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date."}],"balance_after":70773,"source":{"system":"sec-edgar","filing":"0000943819-25-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000164/form4.xml","form_type":"4"}},{"id":996804,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock Options","published_at":"2025-11-18T21:59:27.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":false,"shares":11442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full."}],"balance_after":0,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":11442},"source":{"system":"sec-edgar","filing":"0000943819-25-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000122/form4.xml","form_type":"4"}},{"id":996803,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-11-18T21:59:27.000Z","date":"2025-11-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7314,"price":244.46,"value":1787980.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding and cost to exercise the options granted on 11/14/2018."}],"balance_after":70238,"source":{"system":"sec-edgar","filing":"0000943819-25-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000122/form4.xml","form_type":"4"}},{"id":996802,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common  Stock","published_at":"2025-11-18T21:59:27.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":true,"shares":11442,"price":101.64,"value":1162964.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full."}],"balance_after":77552,"source":{"system":"sec-edgar","filing":"0000943819-25-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000122/form4.xml","form_type":"4"}},{"id":1000932,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-11-13T22:39:56.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":252.05,"value":504100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025."}],"balance_after":66110,"source":{"system":"sec-edgar","filing":"0000943819-25-000117","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000117/form4.xml","form_type":"4"}},{"id":1000931,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-11-13T22:39:56.000Z","date":"2025-11-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":162.953,"price":250.1,"value":40754.5453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024."}],"balance_after":68110,"source":{"system":"sec-edgar","filing":"0000943819-25-000117","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000117/form4.xml","form_type":"4"}},{"id":1093196,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-07-03T16:01:23.000Z","date":"2025-07-02","kind":"sale","planned":true,"acquired":false,"shares":945,"price":255.49,"value":241438.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":68273,"source":{"system":"sec-edgar","filing":"0000943819-25-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000026/form4.xml","form_type":"4"}},{"id":1114722,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:02:07.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000878","document":"e664624_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380525000878/e664624_4-farrell.xml","form_type":"4"}},{"id":1120341,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-06-06T19:22:36.000Z","date":"2025-06-04","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":247.32,"value":494640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":69218,"source":{"system":"sec-edgar","filing":"0000943819-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000013/form4.xml","form_type":"4"}},{"id":1155437,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-05-08T21:38:05.000Z","date":"2025-05-07","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":242.25,"value":484500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":71218,"source":{"system":"sec-edgar","filing":"0001127602-25-013743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225013743/form4.xml","form_type":"4"}},{"id":1178077,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-04-04T16:47:31.000Z","date":"2025-04-02","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":219.74,"value":439480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":73218,"source":{"system":"sec-edgar","filing":"0001127602-25-011625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225011625/form4.xml","form_type":"4"}},{"id":1220591,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-03-06T22:40:28.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":227.71,"value":455420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":75218,"source":{"system":"sec-edgar","filing":"0001127602-25-008593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225008593/form4.xml","form_type":"4"}},{"id":1282684,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-02-05T21:49:30.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":242.11,"value":484220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":77218,"source":{"system":"sec-edgar","filing":"0001127602-25-003232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225003232/form4.xml","form_type":"4"}},{"id":1316657,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2025-01-03T21:57:45.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":230.99,"value":461980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":79218,"source":{"system":"sec-edgar","filing":"0001127602-25-000487","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225000487/form4.xml","form_type":"4"}},{"id":1342048,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-12-05T23:44:08.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":245.65,"value":491300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":81218,"source":{"system":"sec-edgar","filing":"0001127602-24-028741","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224028741/form4.xml","form_type":"4"}},{"id":1351583,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed  Common Stock Options","published_at":"2024-11-27T00:49:25.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":1468,"price":249.56,"value":366354.08,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date."}],"balance_after":1468,"derivative":{"exercise_price":249.56,"exercise_date":"2025-11-11","expiration_date":"2031-11-25","underlying":"ResMed Common Stock","underlying_shares":1468},"source":{"system":"sec-edgar","filing":"0001127602-24-028139","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224028139/form4.xml","form_type":"4"}},{"id":1355012,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-11-22T21:01:54.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date."}],"balance_after":83218,"source":{"system":"sec-edgar","filing":"0001127602-24-027893","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027893/form4.xml","form_type":"4"}},{"id":1369847,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-11-12T23:01:03.000Z","date":"2024-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":527.905,"price":252.38,"value":133232.6639,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023."}],"balance_after":82676,"source":{"system":"sec-edgar","filing":"0001127602-24-027102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027102/form4.xml","form_type":"4"}},{"id":1372002,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-11-08T18:15:09.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":248.74,"value":497480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":83204,"source":{"system":"sec-edgar","filing":"0001127602-24-026799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224026799/form4.xml","form_type":"4"}},{"id":1395463,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-10-02T20:20:46.000Z","date":"2024-10-02","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":237.2,"value":474400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":85204,"source":{"system":"sec-edgar","filing":"0001127602-24-024898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224024898/form4.xml","form_type":"4"}},{"id":1413118,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-09-06T19:01:09.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":239.9,"value":479800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024"}],"balance_after":87204,"source":{"system":"sec-edgar","filing":"0001127602-24-023609","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224023609/form4.xml","form_type":"4"}},{"id":1474941,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T01:00:10.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":31,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000824","document":"e663725_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380524000824/e663725_4-farrell.xml","form_type":"4"}},{"id":1474940,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-19T01:00:10.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":false,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-24-000824","document":"e663725_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380524000824/e663725_4-farrell.xml","form_type":"4"}},{"id":1474939,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:00:10.000Z","date":"2024-06-14","kind":"exercise","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024."}],"balance_after":55741,"source":{"system":"sec-edgar","filing":"0001193805-24-000824","document":"e663725_4-farrell.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380524000824/e663725_4-farrell.xml","form_type":"4"}},{"id":1512462,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-05-17T15:29:03.000Z","date":"2024-05-15","kind":"gift","planned":false,"acquired":false,"shares":68200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Trust.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."}],"balance_after":89204,"source":{"system":"sec-edgar","filing":"0001127602-24-015779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224015779/form4.xml","form_type":"4"}},{"id":1623490,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-02-23T23:40:35.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":10935,"price":182.6643,"value":1997434.1205,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $182.41 - $183.07. The price reported above reflects the weighted average sale price."}],"balance_after":157404,"source":{"system":"sec-edgar","filing":"0001127602-24-006731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224006731/form4.xml","form_type":"4"}},{"id":1623489,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2024-02-23T23:40:35.000Z","date":"2023-05-03","kind":"sale","planned":false,"acquired":false,"shares":12600,"price":237.1726,"value":2988374.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $236.40 - $237.94. The price reported above reflects the weighted average sale price."}],"balance_after":166896,"source":{"system":"sec-edgar","filing":"0001127602-24-006731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224006731/form4.xml","form_type":"4"}},{"id":1735259,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2023-11-20T23:50:23.000Z","date":"2023-11-16","kind":"grant","planned":false,"acquired":true,"shares":1768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2024, or the annual shareholders meeting in the year following the grant date."}],"balance_after":180939,"source":{"system":"sec-edgar","filing":"0001127602-23-028045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223028045/form4.xml","form_type":"4"}},{"id":1741422,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2023-11-16T00:00:11.000Z","date":"2023-11-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":325.375,"price":143.6,"value":46723.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022."}],"balance_after":179171,"source":{"system":"sec-edgar","filing":"0001127602-23-027459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760223027459/form4.xml","form_type":"4"}},{"id":1816089,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-08-03T20:12:56.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":3131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit is economically equivalent to one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":3131,"derivative":{"underlying":"Common Stock","underlying_shares":3131},"source":{"system":"sec-edgar","filing":"0001193805-23-001073","document":"e618811_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380523001073/e618811_4-farrell.xml","form_type":"4"}},{"id":1816088,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-03T20:12:56.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":11869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":11869,"derivative":{"exercise_price":34.92,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":11869},"source":{"system":"sec-edgar","filing":"0001193805-23-001073","document":"e618811_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380523001073/e618811_4-farrell.xml","form_type":"4"}},{"id":2040092,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T01:40:46.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":11789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":11789,"derivative":{"exercise_price":10.25,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":11789},"source":{"system":"sec-edgar","filing":"0001570562-23-000020","document":"wf-form4_167521563026338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056223000020/wf-form4_167521563026338.xml","form_type":"4"}},{"id":2040091,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T01:40:46.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":8293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer"}],"balance_after":43174,"source":{"system":"sec-edgar","filing":"0001570562-23-000020","document":"wf-form4_167521563026338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056223000020/wf-form4_167521563026338.xml","form_type":"4"}},{"id":2110885,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2022-11-18T22:18:51.000Z","date":"2022-11-16","kind":"grant","acquired":true,"shares":1122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2023, or the annual shareholders meeting in the year following the grant date."}],"balance_after":179496,"source":{"system":"sec-edgar","filing":"0001127602-22-026046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222026046/form4.xml","form_type":"4"}},{"id":2116856,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2022-11-15T23:14:18.000Z","date":"2022-11-11","kind":"tax_withholding","acquired":false,"shares":128,"price":225.18,"value":28823.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021."}],"balance_after":178374,"source":{"system":"sec-edgar","filing":"0001127602-22-025653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222025653/form4.xml","form_type":"4"}},{"id":2127641,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2022-11-02T21:23:04.000Z","date":"2022-10-31","kind":"gift","acquired":false,"shares":4550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Unitrust. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."}],"balance_after":178502,"source":{"system":"sec-edgar","filing":"0001127602-22-024789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222024789/form4.xml","form_type":"4"}},{"id":2127640,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2022-11-02T21:23:04.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":9050,"price":221.9754,"value":2008877.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $217.65 to $224.11. The price reported above reflects the weighted average sale price."}],"balance_after":183052,"source":{"system":"sec-edgar","filing":"0001127602-22-024789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760222024789/form4.xml","form_type":"4"}},{"id":2165261,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-07T00:03:30.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":10000,"price":9.1048,"value":91048.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $9.02 to $9.18. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Peter C. Farrell Trust"}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001570562-22-000127","document":"wf-form4_166250899349421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056222000127/wf-form4_166250899349421.xml","form_type":"4"}},{"id":2220997,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T23:16:49.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This grant represents the annual grant to members of the Board of Directors."}],"balance_after":15000,"derivative":{"exercise_price":16.02,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-22-001024","document":"e621785_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380522001024/e621785_4-farrell.xml","form_type":"4"}},{"id":2425038,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T02:01:14.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":22727,"derivative":{"exercise_price":5.46,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001570562-22-000048","document":"wf-form4_164324885895783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056222000048/wf-form4_164324885895783.xml","form_type":"4"}},{"id":2425037,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-27T02:01:14.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":15568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer"}],"balance_after":34881,"source":{"system":"sec-edgar","filing":"0001570562-22-000048","document":"wf-form4_164324885895783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056222000048/wf-form4_164324885895783.xml","form_type":"4"}},{"id":2501487,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock Options","published_at":"2021-11-23T00:45:09.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":1695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant\nDate."}],"balance_after":1695,"derivative":{"exercise_price":263.16,"exercise_date":"2022-11-11","expiration_date":"2028-11-18","underlying":"ResMed Common Stock","underlying_shares":1695},"source":{"system":"sec-edgar","filing":"0000943819-21-000037","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381921000037/primary_doc.xml","form_type":"4"}},{"id":2501486,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2021-11-23T00:45:09.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2022, or the annual shareholder's meeting in the year following the grant date."}],"balance_after":192102,"source":{"system":"sec-edgar","filing":"0000943819-21-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381921000037/primary_doc.xml","form_type":"4"}},{"id":2513669,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2021-11-15T19:03:42.000Z","date":"2021-11-11","kind":"tax_withholding","acquired":false,"shares":342,"price":259.47,"value":88738.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting  of Restricted Stock Units granted 11/19/2020."}],"balance_after":191624,"source":{"system":"sec-edgar","filing":"0001127602-21-029094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221029094/form4.xml","form_type":"4"}},{"id":2601160,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2021-08-17T22:39:01.000Z","date":"2021-08-13","kind":"gift","acquired":false,"shares":36670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Unitrust. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."}],"balance_after":191966,"source":{"system":"sec-edgar","filing":"0001127602-21-023942","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760221023942/form4.xml","form_type":"4"}},{"id":2658586,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:30:31.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This grant represents the annual grant to members of the Board of Directors."}],"balance_after":15000,"derivative":{"exercise_price":35.09,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-21-000925","document":"e620745_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380521000925/e620745_4-farrell.xml","form_type":"4"}},{"id":2871466,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T22:12:39.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":19313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 5, 2021, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":19313,"source":{"system":"sec-edgar","filing":"0001570562-21-000036","document":"wf-form4_161290873618832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056221000036/wf-form4_161290873618832.xml","form_type":"4"}},{"id":2971778,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2020-11-21T00:00:29.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":1187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date."}],"balance_after":228636,"source":{"system":"sec-edgar","filing":"0001127602-20-029753","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029753/form4.xml","form_type":"4"}},{"id":2981941,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2020-11-14T00:01:04.000Z","date":"2020-11-11","kind":"tax_withholding","acquired":false,"shares":579,"price":212.11,"value":122811.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/21/2019."}],"balance_after":227449,"source":{"system":"sec-edgar","filing":"0001127602-20-029031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760220029031/form4.xml","form_type":"4"}},{"id":3100719,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-25T00:00:16.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the options vest monthly over a one year period from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":40.7,"expiration_date":"2030-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-20-000742","document":"e619721_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000119380520000742/e619721_4-farrell.xml","form_type":"4"}},{"id":3302716,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-25T02:06:46.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":23458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":23458,"derivative":{"exercise_price":10.19,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":23458},"source":{"system":"sec-edgar","filing":"0001570562-20-000035","document":"wf-form4_157991798760151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056220000035/wf-form4_157991798760151.xml","form_type":"4"}},{"id":3360355,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true}}],"security":"ResMed Common Stock","published_at":"2019-11-25T20:26:28.000Z","date":"2019-11-21","kind":"grant","acquired":true,"shares":1727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2020, or the annual shareholders meeting in the year following the grant date."}],"balance_after":228028,"source":{"system":"sec-edgar","filing":"0001127602-19-033667","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760219033667/form4.xml","form_type":"4"}},{"id":3386166,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-30T00:07:22.000Z","date":"2019-10-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the options vest monthly over a one year period from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":10.23,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-026109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000089924319026109/doc4.xml","form_type":"4"}},{"id":3431870,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T23:51:52.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":4432,"price":10.85,"value":48087.2,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. 4,100 shares were purchased at a price of $10.86 per share and 332 shares were purchased at a price of $10.72 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By Peter C. Farrell Trust."}],"balance_after":42955,"source":{"system":"sec-edgar","filing":"0000899243-19-022258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000089924319022258/doc4.xml","form_type":"4"}},{"id":3431869,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T23:51:52.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":4681,"price":11.02,"value":51584.62,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By Peter C. Farrell Trust."}],"balance_after":38523,"source":{"system":"sec-edgar","filing":"0000899243-19-022258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000089924319022258/doc4.xml","form_type":"4"}},{"id":3459724,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T20:30:55.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":26163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of July 15, 2019."}],"balance_after":26163,"derivative":{"exercise_price":15.99,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":26163},"source":{"system":"sec-edgar","filing":"0001570562-19-000113","document":"wf-form4_156339544054218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186102/000157056219000113/wf-form4_156339544054218.xml","form_type":"4"}},{"id":3733070,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2018-12-13T23:20:14.000Z","date":"2018-12-13","kind":"gift","acquired":false,"shares":13866,"price":115.395,"value":1600067.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Unitrust.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above represents the average of the high and low trading price on the day of the transaction."}],"balance_after":226301,"source":{"system":"sec-edgar","filing":"0001567619-18-007954","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000156761918007954/doc1.xml","form_type":"4"}},{"id":3762067,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock Options","published_at":"2018-11-17T01:08:23.000Z","date":"2018-11-14","kind":"grant","acquired":true,"shares":11442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date."}],"balance_after":11442,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":11442},"source":{"system":"sec-edgar","filing":"0001567619-18-006569","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000156761918006569/doc1.xml","form_type":"4"}},{"id":3762066,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2018-11-17T01:08:23.000Z","date":"2018-11-09","kind":"tax_withholding","acquired":false,"shares":729,"price":106.94,"value":77959.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2017."}],"balance_after":240167,"source":{"system":"sec-edgar","filing":"0001567619-18-006569","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000156761918006569/doc1.xml","form_type":"4"}},{"id":3944438,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option, representing a right to purchase a total of 6,000 shares, was granted on May 22, 2008 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":39.45,"expiration_date":"2018-05-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944437,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":2130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This RSU award was granted to the Reporting Person on May 18, 2017 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"This RSU award was granted to the Reporting Person on May 18, 2017 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2130},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944436,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":2822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This RSU award was granted to the Reporting Person on May 19, 2016 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This RSU award was granted to the Reporting Person on May 19, 2016 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2822},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944435,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":2501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This RSU award was granted to the Reporting Person on June 12, 2015 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This RSU award was granted to the Reporting Person on June 12, 2015 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2501},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944434,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":3725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3725},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944433,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":2833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This RSU award was granted to the Reporting Person on May 23, 2013 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This RSU award was granted to the Reporting Person on May 23, 2013 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2833},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944432,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":2833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 24, 2012 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 24, 2012 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2833},"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944431,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"tax_withholding","acquired":false,"shares":4777,"price":49.54,"value":236652.58,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Payment of exercise price by Issuer's withholding of shares incident to the respective option exercise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards."}],"balance_after":36713,"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944430,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":6000,"price":39.45,"value":236700.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards."}],"balance_after":41490,"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":3944429,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-07T17:59:14.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":16844,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 3, 2018, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units (\"RSUs\") subject to such deferrals were delivered to the Reporting Person promptly following the Issuer's 2018 Annual Meeting of Stockholders on May 3, 2018, the date on which the Reporting Person retired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards."}],"balance_after":35490,"source":{"system":"sec-edgar","filing":"0001209191-18-028409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028409/doc4.xml","form_type":"4"}},{"id":4129190,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-12-18T21:30:46.000Z","date":"2017-12-18","kind":"gift","acquired":false,"shares":3351,"price":86,"value":288186.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a gift of shares to the Greater Houston Community Foundation.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above represents the average of the high and low trading price on the day of the transaction."}],"balance_after":240896,"source":{"system":"sec-edgar","filing":"0001140361-17-046520","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117046520/doc1.xml","form_type":"4"}},{"id":4129189,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-12-18T21:30:46.000Z","date":"2017-12-15","kind":"gift","acquired":false,"shares":1180,"price":84.97,"value":100264.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a gift of shares to Project Veritas.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above represents the average of the high and low trading price on the day of the transaction."}],"balance_after":244427,"source":{"system":"sec-edgar","filing":"0001140361-17-046520","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117046520/doc1.xml","form_type":"4"}},{"id":4129188,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-12-18T21:30:46.000Z","date":"2017-12-14","kind":"gift","acquired":false,"shares":23689,"price":84.43,"value":2000062.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a gift of shares to the Greater Houston Community Foundation.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above represents the average of the high and low trading price on the day of the transaction."}],"balance_after":245607,"source":{"system":"sec-edgar","filing":"0001140361-17-046520","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117046520/doc1.xml","form_type":"4"}},{"id":4129187,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-12-18T21:30:46.000Z","date":"2017-12-14","kind":"gift","acquired":false,"shares":23689,"price":84.43,"value":2000062.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of shares to the Farrell Family Foundation.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above represents the average of the high and low trading price on the day of the transaction."}],"balance_after":269296,"source":{"system":"sec-edgar","filing":"0001140361-17-046520","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117046520/doc1.xml","form_type":"4"}},{"id":4149506,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-29T22:16:28.000Z","date":"2017-11-28","kind":"gift","acquired":false,"shares":2948,"price":84.8,"value":249990.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift of shares to Donors Trust, Inc.  Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above represents the average of the high and low trading price on the day of the transaction."}],"balance_after":292985,"source":{"system":"sec-edgar","filing":"0001140361-17-044227","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117044227/doc1.xml","form_type":"4"}},{"id":4158924,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-18T02:04:14.000Z","date":"2017-11-16","kind":"grant","acquired":true,"shares":2991,"price":84.98,"value":254175.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2018, or the annual shareholder's meeting in the year following the grant date."}],"balance_after":295933,"source":{"system":"sec-edgar","filing":"0001140361-17-043277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117043277/doc1.xml","form_type":"4"}},{"id":4166414,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Resmed Stock Option Plan","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":82460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents date options first became exercisable. Options vested 1/4 per year."}],"balance_after":0,"derivative":{"exercise_price":27.58,"exercise_date":"2012-11-11","expiration_date":"2018-11-16","underlying":"ResMed Common Stock","underlying_shares":82460},"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166413,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Resmed Stock Option Plan","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":3625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents date options first became exercisable. Options vested 1/4 per year."}],"balance_after":0,"derivative":{"exercise_price":27.58,"exercise_date":"2012-11-11","expiration_date":"2018-11-16","underlying":"ResMed Common Stock","underlying_shares":3625},"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166412,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Resmed Stock Option Plan","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":20492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents date options first became exercisable. Options vested 1/4 per year."}],"balance_after":0,"derivative":{"exercise_price":58.24,"exercise_date":"2016-11-11","expiration_date":"2022-11-19","underlying":"ResMed Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166411,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Resmed Stock Option Plan","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":false,"shares":11815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents date options first became exercisable. Options vested 1/4 per year."}],"balance_after":0,"derivative":{"exercise_price":52.02,"exercise_date":"2015-11-11","expiration_date":"2021-11-19","underlying":"ResMed Common Stock","underlying_shares":11815},"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166410,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-10","kind":"tax_withholding","acquired":false,"shares":1858,"price":83.06,"value":154325.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016."}],"balance_after":292942,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166409,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":82460,"price":82.7,"value":6819442.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from 82.49 to 82.89.  The price reported above represents the weighted average sales price."}],"balance_after":294800,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166408,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":3625,"price":82.69,"value":299751.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $82.51 to $82.82. The price reported above reflects the weighted average sale price."}],"balance_after":377260,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166407,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":20492,"price":82.7,"value":1694688.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from 82.53 to 82.87.  The price reported above represents the weighted average sales price."}],"balance_after":380885,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166406,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":11815,"price":82.71,"value":977218.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from 82.51 to 82.88.  The price reported above represents the weighted average sales price."}],"balance_after":401377,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166405,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":82460,"price":27.58,"value":2274246.8,"ownership":{"direct":true},"balance_after":413192,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166404,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":3625,"price":27.58,"value":99977.5,"ownership":{"direct":true},"balance_after":330732,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166403,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":20492,"price":58.24,"value":1193454.08,"ownership":{"direct":true},"balance_after":327107,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4166402,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-13T22:42:10.000Z","date":"2017-11-09","kind":"exercise","acquired":true,"shares":11815,"price":52.02,"value":614616.3,"ownership":{"direct":true},"balance_after":306615,"source":{"system":"sec-edgar","filing":"0001140361-17-042207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117042207/doc1.xml","form_type":"4"}},{"id":4169444,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Resmed Stock Option Plan","published_at":"2017-11-08T21:28:23.000Z","date":"2017-11-06","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first became exercisable. Options vested 1/4 per year."}],"balance_after":82460,"derivative":{"exercise_price":27.58,"exercise_date":"2012-11-11","expiration_date":"2018-11-16","underlying":"ResMed Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-17-041597","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117041597/doc1.xml","form_type":"4"}},{"id":4169443,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-08T21:28:23.000Z","date":"2017-11-06","kind":"sale","acquired":false,"shares":2000,"price":83.817,"value":167634.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $83.76 to $83.93. The price reported above reflects the weighted average sale price."}],"balance_after":294800,"source":{"system":"sec-edgar","filing":"0001140361-17-041597","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117041597/doc1.xml","form_type":"4"}},{"id":4169442,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":2693,"kind":"person","name":"FARRELL PETER C","position":1,"cik":"0001186102","reported_name":"FARRELL PETER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ResMed Common Stock","published_at":"2017-11-08T21:28:23.000Z","date":"2017-11-06","kind":"sale","acquired":false,"shares":18000,"price":83.497,"value":1502946.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from 82.75 to 83.75.  The price reported above represents the weighted average sales price."}],"balance_after":296800,"source":{"system":"sec-edgar","filing":"0001140361-17-041597","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000114036117041597/doc1.xml","form_type":"4"}}],"next_cursor":"2017-11-08T21:28:23.000000Z,4169442"}